Does Blue Cross Blue Shield (BCBS) Cover Synvisc?
Blue Cross Blue Shield (BCBS) coverage for Synvisc varies by plan. Some Blue Cross Blue Shield (BCBS) plans cover viscosupplementation injections including Synvisc, while others may exclude or restrict coverage. Always verify your specific plan before scheduling.
BCBS coverage varies significantly by state plan. BCBS Illinois excluded viscosupplementation from coverage for policies renewing on or after January 1, 2026. Most other state BCBS plans continue to cover HA injections with prior authorization.
Contains avian-derived hyaluronic acid. Patients with bird or poultry allergies should discuss alternatives with their doctor.
Blue Cross Blue Shield (BCBS) Coverage Criteria for Synvisc
To get Synvisc approved through Blue Cross Blue Shield (BCBS), you typically need to meet the following criteria:
Prior Authorization: Yes. Prior authorization is required before Synvisc is administered. Your provider’s office typically submits this request on your behalf.
Step Therapy / Conservative Care: Blue Cross Blue Shield (BCBS) requires documented failure of conservative treatments before approving Synvisc. This typically includes:
- Physical therapy (usually 6–12 weeks minimum)
- NSAIDs or other oral anti-inflammatory medications
- In some cases, a trial of corticosteroid injections
Medical Necessity: Your treating physician must document:
- A confirmed diagnosis of knee osteoarthritis (X-ray evidence of joint space narrowing)
- Functional impairment affecting daily activities
- Why Synvisc is appropriate for your specific case
Network Requirements: Blue Cross Blue Shield (BCBS) typically requires the injection to be performed by an in-network provider. Kaiser Permanente members must receive care within the Kaiser system.
How to Get Synvisc Approved by Blue Cross Blue Shield (BCBS)
Follow these steps to maximize your approval odds:
- Verify your specific BCBS state plan covers viscosupplementation (call the number on your insurance card)
- Confirm you are NOT on a BCBS Illinois commercial plan renewed after Jan 1 2026
- Obtain documentation of your knee OA diagnosis and failed conservative treatments
- Ask your provider to submit a prior authorization request
- Receive approval confirmation before scheduling the injection series
Pro tip: Ask your provider’s office to handle the prior authorization submission — they typically know the exact documentation Blue Cross Blue Shield (BCBS) requires and can respond to information requests faster.
What If Blue Cross Blue Shield (BCBS) Denies Synvisc?
Denials happen, but they are not final. BCBS denials most often occur due to plan exclusions (especially BCBS Illinois plans post-2026), lack of prior authorization, or insufficient documentation of conservative therapy failure.
Your appeal options:
-
Internal appeal — Request a formal reconsideration from Blue Cross Blue Shield (BCBS). You typically have 30–180 days from the denial date. Include additional clinical documentation from your physician.
-
Peer-to-peer review — Your doctor calls Blue Cross Blue Shield (BCBS)‘s medical reviewer directly to discuss your case. This resolves many denials at the clinical level.
-
External appeal — If Blue Cross Blue Shield (BCBS) upholds the internal denial, you can request an independent external review through your state insurance commissioner’s office.
-
State insurance department complaint — If you believe the denial violates your plan’s terms, file a complaint with your state insurance regulator.
Keep copies of all denial letters, your medical records, and all correspondence. Time limits on appeals are strict.
Synvisc vs. Alternatives Under Blue Cross Blue Shield (BCBS)
BCBS plans vary by state; some state plans have preferred brand lists. Check with your local BCBS plan for brand-specific requirements.
Common alternatives that may be covered under Blue Cross Blue Shield (BCBS):
| Brand | Injections | Source | Approved |
|---|---|---|---|
| Synvisc | 3 weekly injections | Avian-derived | Varies by plan |
| Euflexxa | 3 weekly | Non-avian | Yes (with prior auth) |
| Durolane | Single | Non-avian | Yes (with prior auth) |
| Synvisc-One | Single | Avian | Yes (with prior auth) |
| Monovisc | Single | Non-avian | Yes (with prior auth) |
Your doctor can prescribe the brand that fits your clinical needs and your Blue Cross Blue Shield (BCBS) plan’s formulary.
Frequently Asked Questions
Does Blue Cross Blue Shield (BCBS) require prior authorization for Synvisc?
Yes, Blue Cross Blue Shield (BCBS) requires prior authorization for Synvisc. Your provider submits the request with clinical documentation before the injection. Do not receive the injection before authorization is confirmed.
How many Synvisc injections does Blue Cross Blue Shield (BCBS) cover?
Synvisc is administered as 3 weekly injections. Blue Cross Blue Shield (BCBS) typically covers the full standard injection course when prior authorization is approved and medical necessity is documented. Some plans may limit coverage to one injection series per knee per year.
Can I appeal a Synvisc denial from Blue Cross Blue Shield (BCBS)?
Yes. Blue Cross Blue Shield (BCBS) is required by federal and state law to provide an appeals process for coverage denials. You have the right to an internal appeal and, if that fails, an external independent review. Your doctor can also request a peer-to-peer review with Blue Cross Blue Shield (BCBS)‘s medical director. Engage your provider’s billing team to help navigate the process.
Coverage information reflects general Blue Cross Blue Shield (BCBS) policies as of 2026. Individual plan benefits vary. Always verify your specific plan coverage by calling the member services number on your insurance card before scheduling procedures.